Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × Resistance Training × Clear all

Phase

Phase NA 8 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcopenia 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pharyngeal Neoplasms 1 Obesity 1 Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1

Interventions

Docetaxel 122 Prednisone 105 Abiraterone Acetate 79 Leuprolide 76 enzalutamide 74 Radiotherapy 49 Goserelin 48 bicalutamide 45 Magnetic Resonance Spectroscopy 45 Androgen Antagonists 42 apalutamide 39 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 39 Radiosurgery 30 abiraterone 29 cabazitaxel 28 Gonadotropin-Releasing Hormone 26 Specimen Handling 25 Carboplatin 25 gallium 68 PSMA-11 23 darolutamide 23 Estramustine 22 Metformin 21 luprolide acetate gel depot 20 relugolix 19 Triptorelin Pamoate 19 Radiation 18 Pluvicto 18 Brachytherapy 18 sipuleucel-T 16 prednylidene 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06271551 2024-02-21

ESTRACISE

Central Finland Hospital District

Phase 2 Not yet recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡